Back to search
FDAFDA · Food and drugs·Recall number Z-0058-2019

VITROS Immunodiagnostic Products - Folate Reagent Pack(10758750009237) 1513266

Published October 10, 2018 · Recall initiated: July 12, 2018

Summary

FDA records medical device Class II recall Z-0058-2019, published October 10, 2018 and initiated July 12, 2018. Recalling firm: Ortho Clinical Diagnostics Inc; Status: Ongoing; Reported quantity: 7880; Lot: 2470 2480 2490 2501 2510 2521. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The recalling firm determined that biased results may occur for specific VITROS Immunodiagnostic Products (MicroWell Assays) at biotin concentrations which are lower than indicated in the current Instructions For Use (IFU). Patients who are taking biotin supplements could potentially have biased sample results for affected assays at biotin concentrations lower than indicated in the current IFU.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ortho Clinical Diagnostics Inc
Distributor
Worldwide Distribution - US Nationwide distribution, and countries of Australia, Bermuda, Brazil, Canada, Chile, China, Colombia, India, Japan, Mexico, Singapore, United Kingdom, France, Germany, Italy, Spain, Portugal, Poland, Russia, Denmark, Norway, Sweden, Belgium, and Netherlands.
Lot
2470 2480 2490 2501 2510 2521
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was VITROS Immunodiagnostic Products - Folate Reagent Pack(10758750009237) 1513266 recalled?

Yes. FDA published recall Z-0058-2019 on October 10, 2018. Reported hazard: The recalling firm determined that biased results may occur for specific VITROS Immunodiagnostic Products (MicroWell Assays) at biotin concentrations which are lower than indicated in the current Instructions For Use (IFU). Patients who are taking biotin supplements could potentially have biased sample results for affected assays at biotin concentrations lower than indicated in the current IFU.

What should I do if I have this product?

Voluntary: Firm initiated · Letter